Steve Ford

2014 London Summit - Collaborating to Fund Bioscience

Margaret Anne Craig, Steve Ford, David Loew, Mark Treherne, John Reed, Margaret Anderson

Industry leaders and UK government officials convened to address the critical friction of clinical trial attrition, highlighting exponential biotech growth in European hubs alongside the urgent need for new biomarkers to de-risk neurodegeneration research. Major pharmaceutical players like Roche and Sanofi are engaging in pre-competitive collaborations to pool data and reduce sample sizes, while academic institutions face pressure to shift from publishing-centric models toward translational commercialization. Simultaneously, patient advocacy groups and policymakers are advocating for consolidated funding strategies and digital tools to align European charitable efforts with US-scale initiatives and accelerate the development of disease-modifying therapies.